Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for CorMedix (CRMD) over the last 5 years, with Q3 2025 value amounting to -$2.4 million.

  • CorMedix's Other Operating Expenses fell 13556.14% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year decrease of 3183.61%. This contributed to the annual value of $28.7 million for FY2024, which is 5863.16% up from last year.
  • CorMedix's Other Operating Expenses amounted to -$2.4 million in Q3 2025, which was down 13556.14% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Other Operating Expenses registered a high of $8.3 million during Q4 2024, and its lowest value of -$2.4 million during Q3 2025.
  • Its 3-year average for Other Operating Expenses is $4.9 million, with a median of $6.3 million in 2024.
  • In the last 5 years, CorMedix's Other Operating Expenses skyrocketed by 12686.53% in 2024 and then plummeted by 13556.14% in 2025.
  • CorMedix's Other Operating Expenses (Quarter) stood at $4.1 million in 2023, then surged by 103.62% to $8.3 million in 2024, then tumbled by 129.04% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, $6.4 million for Q2 2025, and $4.5 million during Q1 2025.